デフォルト表紙
市場調査レポート
商品コード
1319075

経口固形剤受託製造市場:製品、メカニズム、エンドユーザー別-2023-2030年の世界予測

Oral Solid Dosage Contract Manufacturing Market by Product, Mechanism, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
経口固形剤受託製造市場:製品、メカニズム、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経口固形剤受託製造の世界市場は、2023年に408億3,000万米ドル、CAGR 8.56%で大きく成長し、2030年には729億1,000万米ドルという驚異的な規模に達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の経口固形剤受託製造市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.経口固形剤受託製造の世界市場規模および予測は?

2.予測期間中、世界の経口固形剤受託製造市場を形成するCOVID-19の阻害要因と影響は?

3.経口固形剤受託製造の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.経口固形剤受託製造の世界市場における競争戦略は?

5.経口固形剤受託製造の世界市場における技術動向と規制の枠組みは?

6.経口固形剤受託製造の世界市場における主要ベンダーの市場シェアは?

7.経口固形剤受託製造の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製薬会社によるアウトソーシングサービスの導入が増加
      • 特許失効とジェネリック医薬品製造の増加
      • 費用対効果の高い医薬品開発プロセスの必要性
    • 抑制要因
      • 経験豊富な技術スタッフの不足
    • 機会
      • 医薬品開発技術の進歩の増加
      • 経口固形製剤(OSD)の開発拡大に向けたCDMOによる投資の増加
    • 課題
      • 規制当局による厳しい承認基準
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 経口固形剤受託製造市場:製品別

  • カプセル
  • 顆粒
  • グミ
  • トローチ
  • トローチ
  • 粉末
  • タブレット

第7章 経口固形剤受託製造市場:機構別

  • 制御放出
  • 遅延リリース
  • 即時リリース

第8章 経口固形剤受託製造市場:エンドユーザー別

  • 大企業
  • 中小企業
  • 新興企業とジェネリック医薬品会社

第9章 南北アメリカの経口固形剤受託製造市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の経口固形剤受託製造市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの経口固形剤受託製造市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2022 VS 2030 (%)
  • FIGURE 6. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET DYNAMICS
  • FIGURE 9. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY GUMMIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PASTILLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 13. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY CONTROLLED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY DELAYED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY IMMEDIATE-RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY LARGE-SIZE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MEDIUM- & SMALL-SIZE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STARTUPS & GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 148. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 149. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET LICENSE & PRICING
目次
Product Code: MRR-0D217D5AE62B

The Global Oral Solid Dosage Contract Manufacturing Market is forecasted to grow significantly, with a projected USD 40.83 billion in 2023 at a CAGR of 8.56% and expected to reach a staggering USD 72.91 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Oral Solid Dosage Contract Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Oral Solid Dosage Contract Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Capsules, Granules, Gummies, Lozenges, Pastilles, Powders, and Tablets. The Pastilles is projected to witness significant market share during forecast period.

Based on Mechanism, market is studied across Controlled-Release, Delayed-Release, and Immediate-Release. The Immediate-Release is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Large-Size Companies, Medium- & Small-Size Companies, and Startups & Generic Pharmaceutical Companies. The Large-Size Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Oral Solid Dosage Contract Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oral Solid Dosage Contract Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Solid Dosage Contract Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Solid Dosage Contract Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Oral Solid Dosage Contract Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Oral Solid Dosage Contract Manufacturing Market?

6. What is the market share of the leading vendors in the Global Oral Solid Dosage Contract Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Oral Solid Dosage Contract Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Oral Solid Dosage Contract Manufacturing Market, by Product, 2022 vs 2030
  • 4.3. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2022 vs 2030
  • 4.4. Oral Solid Dosage Contract Manufacturing Market, by End-User, 2022 vs 2030
  • 4.5. Oral Solid Dosage Contract Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of outsourcing services by pharmaceutical companies
      • 5.1.1.2. Increasing patent expiration and generic drug manufacturing
      • 5.1.1.3. Need for cost-effective drug development process
    • 5.1.2. Restraints
      • 5.1.2.1. Less availability of experienced technical staff
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in the advancement of drug development technology
      • 5.1.3.2. Rising investments by CDMOs to expand the oral solid dosage (OSD) development
    • 5.1.4. Challenges
      • 5.1.4.1. Strict approval criteria by regulatory authorities
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Oral Solid Dosage Contract Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Granules
  • 6.4. Gummies
  • 6.5. Lozenges
  • 6.6. Pastilles
  • 6.7. Powders
  • 6.8. Tablets

7. Oral Solid Dosage Contract Manufacturing Market, by Mechanism

  • 7.1. Introduction
  • 7.2. Controlled-Release
  • 7.3. Delayed-Release
  • 7.4. Immediate-Release

8. Oral Solid Dosage Contract Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Large-Size Companies
  • 8.3. Medium- & Small-Size Companies
  • 8.4. Startups & Generic Pharmaceutical Companies

9. Americas Oral Solid Dosage Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oral Solid Dosage Contract Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing